Genito-palato-cardiac syndrome
disease diseaseOn this page
Also known as Gardner-Silengo-Wachtel syndromegenito palato cardiac syndrome
Summary
Genito-palato-cardiac syndrome (MONDO:0009270) is a disease. A subtype of endocrine system disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Prevalence: <1 / 1 000 000 (Worldwide) [Orphanet-validated]
- Phenotypes (HPO): 25
Clinical features
Epidemiology
Prevalence records
2 prevalence record(s), Orphanet:
| Type | Class | Value | Geography | Validation |
|---|---|---|---|---|
| Cases/families | 15 | Worldwide | Validated | |
| Point prevalence | <1 / 1 000 000 | Worldwide | Validated |
Signs & symptoms
Clinical features (HPO)
25 HPO clinical features (Orphanet curated; top 25 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0000037 | Male pseudohermaphroditism | Very frequent (80-99%) |
| HP:0000175 | Cleft palate | Very frequent (80-99%) |
| HP:0000347 | Micrognathia | Very frequent (80-99%) |
| HP:0000369 | Low-set ears | Very frequent (80-99%) |
| HP:0001511 | Intrauterine growth retardation | Very frequent (80-99%) |
| HP:0001671 | Abnormal cardiac septum morphology | Very frequent (80-99%) |
| HP:0030680 | Abnormal cardiovascular system morphology | Very frequent (80-99%) |
| HP:0100335 | Non-midline cleft of the upper lip | Very frequent (80-99%) |
| HP:0000028 | Cryptorchidism | Frequent (30-79%) |
| HP:0000047 | Hypospadias | Frequent (30-79%) |
| HP:0000494 | Downslanted palpebral fissures | Frequent (30-79%) |
| HP:0008668 | Gonadal dysgenesis, male | Frequent (30-79%) |
| HP:0000003 | Multicystic kidney dysplasia | Occasional (5-29%) |
| HP:0000238 | Hydrocephalus | Occasional (5-29%) |
| HP:0000252 | Microcephaly | Occasional (5-29%) |
| HP:0000316 | Hypertelorism | Occasional (5-29%) |
| HP:0000431 | Wide nasal bridge | Occasional (5-29%) |
| HP:0000776 | Congenital diaphragmatic hernia | Occasional (5-29%) |
| HP:0001156 | Brachydactyly | Occasional (5-29%) |
| HP:0001162 | Postaxial hand polydactyly | Occasional (5-29%) |
| HP:0002650 | Scoliosis | Occasional (5-29%) |
| HP:0002714 | Downturned corners of mouth | Occasional (5-29%) |
| HP:0002808 | Kyphosis | Occasional (5-29%) |
| HP:0005264 | Abnormality of the gallbladder | Occasional (5-29%) |
| HP:0100016 | Abnormality of mesentery morphology | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | genito-palato-cardiac syndrome |
| Mondo ID | MONDO:0009270 |
| MeSH | C537683 |
| OMIM | 231060 |
| Orphanet | 2075 |
| ICD-11 | 2011995320 |
| UMLS | C1856466 |
| MedGen | 341558 |
| GARD | 0002460 |
| Is cancer (heuristic) | no |
Also known as: Gardner-Silengo-Wachtel syndrome · genito palato cardiac syndrome
Disease family
This is a subtype of endocrine system disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › endocrine system disorder › genito-palato-cardiac syndrome
Related subtypes (47): autoimmune disorder of endocrine system, parathyroid gland disorder, endocrine gland neoplasm, gonadal disorder, pancreas disorder, thyroid gland disorder, pituitary gland disorder, thymus gland disorder, liver disorder, adrenal gland disorder, hyperinsulinemic hypoglycemia, non-neoplastic bile duct disorder, endocrine tuberculosis, campomelic dysplasia, polycystic ovary syndrome, dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome, hypohidrotic ectodermal dysplasia-hypothyroidism-ciliary dyskinesia syndrome, hypoinsulinemic hypoglycemia and body hemihypertrophy, Bamforth-Lazarus syndrome, blepharophimosis - intellectual disability syndrome, SBBYS type, Wolfram-like syndrome, hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, estrogen resistance syndrome, short stature, microcephaly, and endocrine dysfunction, polyendocrinopathy, pituitary deficiency, hereditary endocrine growth disease, diencephalic syndrome, muscular pseudohypertrophy-hypothyroidism syndrome, neonatal iodine exposure, disorders of vitamin D metabolism, rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome, duplication of the pituitary gland, familial hypocalciuric hypercalcemia, hypothalamic adipsic hypernatraemia syndrome, Leydig cell hypoplasia, inherited obesity, beta thalassemia, thyroid hormone metabolism, abnormal, neuroendocrine disorder, NKX2-1 related choreoathetosis and congenital hypothyroidism with or without pulmonary dysfunction, parneoplastic endocrine syndrome, 17,20-lyase deficiency, isolated, 17-alpha-hydroxylase/17,20-lyase deficiency, combined complete, 17-alpha-hydroxylase/17,20-lyase deficiency, combined partial, disorder of GNAS inactivation, acquired hypothalamic obesity
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.